Life’s Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast Cancer
Elena Wadden(University of Washington), Richard K. Cheng(University of Washington), Ramesh Mazhari(George Washington University), Nazmus Saquib(Sulaiman Al Rajhi Colleges), Ana Barac(Inova Fairfax Hospital), Yangbo Sun(University of Tennessee Health Science Center), Vidhushei Yogeswaran(University of Washington), Lisa W. Martin(George Washington University), Kerryn W. Reding(University of Washington), Marcia L. Stefanick(Stanford University), Alexi Vasbinder(University of Washington), Michael S. Simon(Exponent (United States)), JoAnn E. Manson(Brigham and Women's Hospital), Aladdin H. Shadyab(University of California San Diego)
Cited by 14
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
|JAMA|2007|1.7k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
|New England Journal of Medicine|2006|985
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767